Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Vangrevelinghe

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Heliyon|November 27, 2019
Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonistChie Koshiishi, Takanori Kanazawa, Eric Vangrevelinghe, et al.
Journal of Medicinal Chemistry|June 13, 2003
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput dockingEric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
Journal of Medicinal Chemistry|December 16, 2010
Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase familyGebhard Thoma, Francois Nuninger, Rocco Falchetto, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/βMaurice J van Eis, JeanPierre Evenou, Walter Schuler, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2015
Orally bioavailable Syk inhibitors with activity in a rat PK/PD modelGebhard Thoma, Siem Veenstra, Ross Strang, et al.
Journal of Medicinal Chemistry|April 19, 2002
Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimicsJoseph Schoepfer, Heinz Fretz, Bhabatosh Chaudhuri, et al.
ACS Chemical Biology|February 15, 2019
Discovery and Structural Characterization of ATP-Site Ligands for the Wild-Type and V617F Mutant JAK2 Pseudokinase DomainRandall McNally, Qing Li, Kunhua Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Novel ROCK inhibitors for the treatment of pulmonary arterial hypertensionDuncan Shaw, Greg Hollingworth, Nicolas Soldermann, et al.
Journal of Medicinal Chemistry|January 31, 2015
Discovery and profiling of a selective and efficacious Syk inhibitorGebhard Thoma, Alexander B Smith, Maurice J van Eis, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Heliyon|November 27, 2019
Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonistChie Koshiishi, Takanori Kanazawa, Eric Vangrevelinghe, et al.
Journal of Medicinal Chemistry|June 13, 2003
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput dockingEric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
Journal of Medicinal Chemistry|December 16, 2010
Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase familyGebhard Thoma, Francois Nuninger, Rocco Falchetto, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/βMaurice J van Eis, JeanPierre Evenou, Walter Schuler, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2015
Orally bioavailable Syk inhibitors with activity in a rat PK/PD modelGebhard Thoma, Siem Veenstra, Ross Strang, et al.
Journal of Medicinal Chemistry|April 19, 2002
Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimicsJoseph Schoepfer, Heinz Fretz, Bhabatosh Chaudhuri, et al.
ACS Chemical Biology|February 15, 2019
Discovery and Structural Characterization of ATP-Site Ligands for the Wild-Type and V617F Mutant JAK2 Pseudokinase DomainRandall McNally, Qing Li, Kunhua Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Novel ROCK inhibitors for the treatment of pulmonary arterial hypertensionDuncan Shaw, Greg Hollingworth, Nicolas Soldermann, et al.
Journal of Medicinal Chemistry|January 31, 2015
Discovery and profiling of a selective and efficacious Syk inhibitorGebhard Thoma, Alexander B Smith, Maurice J van Eis, et al.
Pageof 4